The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.
Immunity. 2009 Dec 18;31(6):897-908. doi: 10.1016/j.immuni.2009.09.025.
T cells often alloreact with foreign human leukocyte antigens (HLA). Here we showed the LC13 T cell receptor (TCR), selected for recognition on self-HLA-B( *)0801 bound to a viral peptide, alloreacts with B44 allotypes (HLA-B( *)4402 and HLA-B( *)4405) bound to two different allopeptides. Despite extensive polymorphism between HLA-B( *)0801, HLA-B( *)4402, and HLA-B( *)4405 and the disparate sequences of the viral and allopeptides, the LC13 TCR engaged these peptide-HLA (pHLA) complexes identically, accommodating mimicry of the viral peptide by the allopeptide. The viral and allopeptides adopted similar conformations only after TCR ligation, revealing an induced-fit mechanism of molecular mimicry. The LC13 T cells did not alloreact against HLA-B( *)4403, and the single residue polymorphism between HLA-B( *)4402 and HLA-B( *)4403 affected the plasticity of the allopeptide, revealing that molecular mimicry was associated with TCR specificity. Accordingly, molecular mimicry that is HLA and peptide dependent is a mechanism for human T cell alloreactivity between disparate cognate and allogeneic pHLA complexes.
T 细胞通常会对外来的人类白细胞抗原(HLA)发生同种异体反应。在这里,我们展示了 LC13 T 细胞受体(TCR),它是针对自身 HLA-B( *)0801 结合的病毒肽选择识别的,与两种不同的同种异体肽结合的 B44 同种异型(HLA-B( *)4402 和 HLA-B( *)4405)发生同种异体反应。尽管 HLA-B( *)0801、HLA-B( *)4402 和 HLA-B( *)4405 之间存在广泛的多态性,以及病毒肽和同种异体肽之间存在不同的序列,但 LC13 TCR 以相同的方式与这些肽-HLA(pHLA)复合物结合,同种异体肽模拟病毒肽。只有在 TCR 连接后,病毒肽和同种异体肽才采用相似的构象,揭示了分子模拟的诱导契合机制。LC13 T 细胞不会针对 HLA-B( *)4403 发生同种异体反应,而 HLA-B( *)4402 和 HLA-B( *)4403 之间的单个残基多态性影响了同种异体肽的可塑性,表明分子模拟与 TCR 特异性有关。因此,依赖 HLA 和肽的分子模拟是人类 T 细胞在不同同源和同种异体 pHLA 复合物之间发生同种异体反应的一种机制。